Noxopharm

PO Box 824
Turramurra
New South Wales
2074

Tel: 61-2-9144-2223

Email: info@noxopharm.com

Show jobs for this employer

About Noxopharm

Noxopharm is an Australian drug development company with offices in Melbourne and Sydney. The Company has a primary focus on the development of drugs to address the problem of drug-resistance in cancer cells, the major hurdle facing improved survival prospects for cancer patients. NOX66 is the first pipeline product, with later generation drug candidates under development in an R&D program.
LEADERSHIP:
Founder and CEO: Graham Kelly
CLINICAL TRIAL:
Please click here for clinical trial information.
PRODUCTS:
NOX66

13 articles with Noxopharm